3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
HIV Infections
2
Sarcoma, Kaposi
1
Lymphoma, AIDS-Related
1
Dendritic Cell Sarcoma, Interdigitating
1
Acquired Immunodeficiency Syndrome
1
Interventions
Cyclophosphamide
56
fludarabine phosphate
30
Filgrastim
28
Peripheral Blood Stem Cell Transplantation
27
Radiotherapy
26
Cyclosporine
23
Busulfan
23
Etoposide
21
Mycophenolic Acid
20
Whole-Body Irradiation
19
Antilymphocyte Serum
19
Methotrexate
17
Methylprednisolone
15
Melphalan
14
Cytarabine
13
Vincristine
11
Tacrolimus
11
Thiotepa
10
Prednisone
10
Cord Blood Stem Cell Transplantation
10
Rituximab
9
Doxorubicin
9
Leucovorin
7
aldesleukin
6
Granulocyte Colony-Stimulating Factor
6
sargramostim
5
Psychiatric Rehabilitation
5
Carboplatin
5
Therapeutics
4
Daunorubicin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Dendritic Cell Sarcoma, Interdigitating
×
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
×
Clear all
NCT00799136
2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2
Completed
6 enrolled